-
Something wrong with this record ?
Co-treatment with indole-3-carbinol and resveratrol modify porcine CYP1A and CYP3A activities and expression
G. Zamaratskaia, R. Thøgersen, M. Čandek-Potokar, MK. Rasmussen,
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Cytochrome P-450 CYP1A1 antagonists & inhibitors metabolism MeSH
- Cytochrome P-450 CYP3A genetics metabolism MeSH
- Hepatocytes drug effects MeSH
- Indoles pharmacology MeSH
- Cytochrome P-450 CYP3A Inhibitors pharmacology MeSH
- Food-Drug Interactions MeSH
- Microsomes, Liver drug effects enzymology MeSH
- Swine MeSH
- Receptors, Aryl Hydrocarbon genetics MeSH
- Gene Expression Regulation, Enzymologic drug effects MeSH
- Receptors, Steroid genetics MeSH
- Stilbenes pharmacology MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
1. Humans and animals are commonly exposed to indole-3-carbinol (I3C) and resveratrol (RES) via food or beverages. Moreover, these compounds have been demonstrated to potentially cause food-drug interactions. However, information about their combined effects is limited. Therefore, we investigated the effects of I3C and RES, both as single compounds and in combination, on cytochrome P450 1A and 3A activity and gene expression. 2. Using porcine microsomes, we demonstrated that RES caused non-competitive inhibition of CYP1A activity and un-competitive inhibition of CYP3A activity. Compared to the effect of single compounds, co-treatment with I3C and RES increased a degree of inhibition of CYP1A activity. 3. In porcine primary hepatocytes, treatment with I3C and RES resulted in induction of CYP1A1, CYP1A2 and CYP3A29 mRNA expression. 4. In conclusion, we demonstrated that both RES and I3C could cause food-drug interactions and that the combined effect could be more potent in doing so.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033974
- 003
- CZ-PrNML
- 005
- 20181012111115.0
- 007
- ta
- 008
- 181008s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/00498254.2017.1300708 $2 doi
- 035 __
- $a (PubMed)28316274
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Zamaratskaia, Galia $u a Department of Molecular Sciences , Swedish University of Agricultural Sciences , Uppsala , Sweden. b Faculty of Fisheries and Protection of Waters , South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, University of South Bohemia in Ceske Budejovice , Vodnany , Czech Republic.
- 245 10
- $a Co-treatment with indole-3-carbinol and resveratrol modify porcine CYP1A and CYP3A activities and expression / $c G. Zamaratskaia, R. Thøgersen, M. Čandek-Potokar, MK. Rasmussen,
- 520 9_
- $a 1. Humans and animals are commonly exposed to indole-3-carbinol (I3C) and resveratrol (RES) via food or beverages. Moreover, these compounds have been demonstrated to potentially cause food-drug interactions. However, information about their combined effects is limited. Therefore, we investigated the effects of I3C and RES, both as single compounds and in combination, on cytochrome P450 1A and 3A activity and gene expression. 2. Using porcine microsomes, we demonstrated that RES caused non-competitive inhibition of CYP1A activity and un-competitive inhibition of CYP3A activity. Compared to the effect of single compounds, co-treatment with I3C and RES increased a degree of inhibition of CYP1A activity. 3. In porcine primary hepatocytes, treatment with I3C and RES resulted in induction of CYP1A1, CYP1A2 and CYP3A29 mRNA expression. 4. In conclusion, we demonstrated that both RES and I3C could cause food-drug interactions and that the combined effect could be more potent in doing so.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cytochrom P-450 CYP1A1 $x antagonisté a inhibitory $x metabolismus $7 D019363
- 650 _2
- $a cytochrom P-450 CYP3A $x genetika $x metabolismus $7 D051544
- 650 _2
- $a inhibitory cytochromu P450 CYP3A $x farmakologie $7 D065692
- 650 _2
- $a interakce mezi potravou a léky $7 D018565
- 650 _2
- $a regulace genové exprese enzymů $x účinky léků $7 D015971
- 650 _2
- $a hepatocyty $x účinky léků $7 D022781
- 650 _2
- $a indoly $x farmakologie $7 D007211
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mikrozomy $x účinky léků $x enzymologie $7 D008862
- 650 _2
- $a receptory aromatických uhlovodíků $x genetika $7 D018336
- 650 _2
- $a steroidní receptory $x genetika $7 D011987
- 650 _2
- $a stilbeny $x farmakologie $7 D013267
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Thøgersen, Rebekka $u c Department of Food Science , Aarhus University , Tjele , Denmark.
- 700 1_
- $a Čandek-Potokar, Marjeta $u d Agricultural Institute of Slovenia , Ljubljana , Slovenia , and. e Faculty of Agriculture and Life Sciences , University of Maribor , Hoče , Slovenia.
- 700 1_
- $a Rasmussen, Martin Krøyer $u c Department of Food Science , Aarhus University , Tjele , Denmark.
- 773 0_
- $w MED00004746 $t Xenobiotica; the fate of foreign compounds in biological systems $x 1366-5928 $g Roč. 48, č. 3 (2018), s. 232-240
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28316274 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181012111607 $b ABA008
- 999 __
- $a ok $b bmc $g 1340374 $s 1030968
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 48 $c 3 $d 232-240 $e 20170319 $i 1366-5928 $m Xenobiotica $n Xenobiotica $x MED00004746
- LZP __
- $a Pubmed-20181008